• Euro (EUR) saw marked volatility following Pfizer’s announcement
  • Pfizer covid vaccine 90% effective
  • US Dollar (USD) slides on safe haven outflows, despite covid cases topping 100k for 6th day
  • German ZEW sentiment expected to drop

The Euro US Dollar (EUR/USD) exchange rate is advancing on Tuesday paring some of Monday’s losses. The pair settled in the previous session -0.7% lower at US$1.1813 over 100 pips lower than the high of US$1.1920 reached earlier in the session. At 09:15 UTC, EUR/USD trades +0.25% at US$1.1839.

The Euro has been on a rollercoaster ride since Pfizer announced that its covid-vaccine candidate has been found to be 90% effective in its Phase 3 trial. The news initially sent the Euro surging to a high of $1.1920 on Monday, before rising yields on US treasuries as investors ditched bonds to move into stocks sent the pair charging lower.

Today the euphoria surrounding the vaccine news has calmed, with investors questioning distribution and timeframes involved. However, the mood is broadly upbeat as there is a feeling that there is light at the end of the covid tunnel, although the globe will first need to navigate its way through a very tough winter. The number of cases in the US continues to soar as the third wave takes hold. Just over 59,000 covid-19 patients were in hospitals across the US on Monday, as infections remained over 100,000 for the sixth straight day.

The Pfizer vaccine candidate is one of 11 vaccines which are in the final stages of testing. Other firms such as AstraZeneca, Moderna and Johnson & Johnson which have covid -19 vaccine candidates in Phase 3 trials and following the Pfizer results, these are suddenly looking like real possibilities as well lifting the outlook. The mood is supporting riskier currencies, whilst dragging on demand for the safe haven US Dollar.

Attention will now turn towards German ZEW sentiment data. Sentiment is expected to fall sharply again after tumbling to a 5-month low in October as covid cases rose and lockdown measures tightened. A very weak reading could unnerve investors.